Cargando…
Letter Regarding “Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations”
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751679/ https://www.ncbi.nlm.nih.gov/pubmed/36531869 http://dx.doi.org/10.1016/j.ekir.2022.08.017 |
| _version_ | 1784850530893299712 |
|---|---|
| author | Rico-Fontalvo, Jorge Cabrales, Jose Rodriguez-Yanez, Tomás Daza-Arnedo, Rodrigo |
| author_facet | Rico-Fontalvo, Jorge Cabrales, Jose Rodriguez-Yanez, Tomás Daza-Arnedo, Rodrigo |
| author_sort | Rico-Fontalvo, Jorge |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9751679 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97516792022-12-16 Letter Regarding “Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations” Rico-Fontalvo, Jorge Cabrales, Jose Rodriguez-Yanez, Tomás Daza-Arnedo, Rodrigo Kidney Int Rep Letter to the Editor Elsevier 2022-08-28 /pmc/articles/PMC9751679/ /pubmed/36531869 http://dx.doi.org/10.1016/j.ekir.2022.08.017 Text en © 2022 International Society of Nephrology. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Letter to the Editor Rico-Fontalvo, Jorge Cabrales, Jose Rodriguez-Yanez, Tomás Daza-Arnedo, Rodrigo Letter Regarding “Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations” |
| title | Letter Regarding “Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations” |
| title_full | Letter Regarding “Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations” |
| title_fullStr | Letter Regarding “Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations” |
| title_full_unstemmed | Letter Regarding “Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations” |
| title_short | Letter Regarding “Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations” |
| title_sort | letter regarding “prescribing sglt2 inhibitors in patients with ckd: expanding indications and practical considerations” |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751679/ https://www.ncbi.nlm.nih.gov/pubmed/36531869 http://dx.doi.org/10.1016/j.ekir.2022.08.017 |
| work_keys_str_mv | AT ricofontalvojorge letterregardingprescribingsglt2inhibitorsinpatientswithckdexpandingindicationsandpracticalconsiderations AT cabralesjose letterregardingprescribingsglt2inhibitorsinpatientswithckdexpandingindicationsandpracticalconsiderations AT rodriguezyaneztomas letterregardingprescribingsglt2inhibitorsinpatientswithckdexpandingindicationsandpracticalconsiderations AT dazaarnedorodrigo letterregardingprescribingsglt2inhibitorsinpatientswithckdexpandingindicationsandpracticalconsiderations |